On a standalone basis, Indraprastha Medical Corporation net profit surged 132.3% to Rs 15.10 crore on 1.2% fall in net sales to Rs 198.07 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax soared 154.10% to Rs 20.84 crore in Q4 FY21 as against Rs 8.20 crore in Q4 FY20.During the financial year, Indraprastha Medical Corporation's standalone net profit slumped 94.6% to Rs 2.33 crore on 26.17% fall in revenue from operations to Rs 613.38 crore in FY 2021 over FY 2020.
Indraprastha Medical Corporation is engaged in healthcare business.
Shares of Indraprastha Medical Corporation declined 2.79% to Rs 95.95 on BSE. The stock hit an intraday low of Rs 94.80 and an intraday high of Rs 98.50 so far.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app